Liver and Bile

J Hepatol. 2023;79(2):516–37

Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS

Global burden of liver disease: 2023 update

Liver disease accounts for 2 million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide); approximately two-thirds of all liver-related deaths occur in men. Deaths are largely attributable to complications of cirrhosis and hepatocellular carcinoma (HCC), with acute hepatitis accounting for a smaller proportion of deaths. The most common causes of cirrhosis worldwide are related to viral hepatitis, alcohol, and non-alcoholic fatty liver disease (NAFLD). Hepatotropic viruses are the etiological factor in most cases of acute hepatitis, but drug-induced liver injury increasingly accounts for a significant proportion of cases.

This iteration of the global burden of liver disease is an update of the 2019 version and focuses mainly on areas where significant new information is available like alcohol-associated liver disease, NAFLD, viral hepatitis, and HCC. The authors also devote a separate section to the burden of liver disease in Africa, an area of the world typically neglected in such documents.

S.K. Asrani, M.D., Baylor University Medical Center, Baylor Scott and White, Dallas, TX, USA, E-Mail: sumeet.asrani@bswhealth.org

DOI: 10.1016/j.jhep.2023.03.017

Back to overview

this could be of interest:

A phase 3, randomized trial of bulevirtide in chronic hepatitis D

N Engl J Med. 2023;389(1):22–32

Risk of parenterally transmitted hepatitis following exposure to invasive procedures in Italy: SEIEVA surveillance 2000–2021

J Hepatol. 2023;79(1):61–68

More articles on the topic